Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series) - Image 1

£142.60

CRC Press Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)

Name: Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 166.98 GBP
Availability: InStock

Healing

Price History & Forecast

Last 43 days • 43 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 43 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £143 (23 days, 53.5%)

Price range: £143 - £167

Price levels: 2 different prices over 43 days

Description

One of the hallmarks of the 21st century medicine is the emergence of digital therapeutics (DTx)―evidence-based, clinically validated digital technologies to prevent, diagnose, treat, and manage various diseases and medical conditions. DTx solutions have been gaining interest from patients, investors, healthcare providers, health authorities, and other stakeholders because of the potential of DTx to deliver equitable, massively scalable, personalized and transformative treatments for different unmet medical needs. Digital Therapeutics: Scientific, Statistical, Clinical, and Regulatory Aspects is an unparalleled summary of the current scientific, statistical, developmental, and regulatory aspects of DTx which is poised to become the fastest growing area of the biopharmaceutical and digital medicine product development. This edited volume intends to provide a systematic exposition to digital therapeutics through 19 peer-reviewed chapters written by subject matter experts in this emerging field. This edited volume is an invaluable resource for business leaders and researchers working in public health, healthcare, digital health, information technology, and biopharmaceutical industries. It will be also useful for regulatory scientists involved in the review of DTx products, and for faculty and students involved in an interdisciplinary research on digital health and digital medicine. Key Features: Provides the taxonomy of the concepts and a navigation tool for the field of DTx. Covers important strategic aspects of the DTx industry, thereby helping investors, developers, and regulators gain a better appreciation of the potential value of DTx. Expounds on many existing and emerging state-of-the art scientific and technological tools, as well as data privacy, ethical and regulatory considerations for DTx product development. Presents several case studies of successful development of some of the most remarkable DTx products. Provides some perspectives and forward-looking statements on the future of digital medicine.

Product Specifications

Brand: CRC Press
Format: Hardcover
ASIN: 0367861593
Category: Books > Subjects > Health, Family & Lifestyle > Alternative Medicine > Healing
Domain: Amazon UK
Release Date: 06 December 2022
Listed Since: 09 June 2022

Barcode

No barcode data available

CRC Press Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/CRC Biostatistics)

Translational Medicine: Strategies and Statistical Methods: 28 (Chapman & Hall/CRC Biostatistics)

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Encyclopedia of Biopharmaceutical Statistics - Four Volume Set

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/Crc Biostatistics)

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Pharmaceutical Care in Digital Revolution: Insights Towards Circular Innovation

Quantitative Methods for Traditional Chinese Medicine Development (Chapman & Hall/Crc Biostatistics)

Quantitative Methods for Traditional Chinese Medicine Development: 83 (Chapman & Hall/CRC Biostatistics)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Re-inventing Drug Development - CRC Press Biopharma Book

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)

Digital Therapeutics for Mental Health and Addiction: The State of the Science and Vision for the Future

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

Biopharmaceuticals: Challenges and Opportunities

The Digital Transformation of Product Formulation: Concepts, Challenges, and Applications for Accelerated Innovation

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Manual of Digital Health: Informatics, Analytics, Therapeutics, Telehealth, and Regulations